Ryan Nipp to Bevacizumab
This is a "connection" page, showing publications Ryan Nipp has written about Bevacizumab.
Connection Strength
0.113
-
Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer? Oncologist. 2015 Mar; 20(3):236-8.
Score: 0.113
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.